Norika Katagiri Selected Research

1- 3- methylbutyryl- N4- 6- aminohexanoyl- piperazine

1/2021

Nociceptive Sensitization by Activation of Protease-Activated Receptor 2 in a Rat Model of Incisional Pain.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Norika Katagiri Research Topics

Disease

2	Hyperalgesia 01/2021 - 01/2021
2	Pain (Aches) 01/2021 - 01/2021
2	Postoperative Pain 01/2021 - 01/2020
1	Hypersensitivity (Allergy) 01/2021
1	Acute Pain 01/2020
1	Opioid-Induced Constipation 01/2020
1	Dystonia (Limb Dystonia) 01/2020
1	Toxic Megacolon 01/2020
1	Postoperative Nausea and Vomiting (PONV) 01/2020
1	Ileus 01/2020

Drug/Important Bio-Agent (IBA)

2	Opioid Analgesics (Opioids)IBA 01/2021 - 01/2020
1	1- 3- methylbutyryl- N4- 6- aminohexanoyl- piperazineIBA 01/2021
1	PAR-2 ReceptorIBA 01/2021
1	seryl- leucyl- isoleucyl- glycyl- - arginyl- leucinamideIBA 01/2021
1	Magnesium Sulfate (Sulfate, Magnesium)FDA LinkGeneric 01/2021
1	Ketamine FDA LinkGeneric 01/2021
1	Droperidol FDA LinkGeneric 01/2020
1	Pentazocine (Talwin)FDA LinkGeneric 01/2020

Therapy/Procedure

1	Oral Surgery (Maxillofacial Surgery) 01/2020
1	Patient-Controlled Analgesia (Analgesia, Patient Controlled) 01/2020